We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




FDA Clears Antibiotic-Delivering Spacer for Infected Knee Replacements

By HospiMedica International staff writers
Posted on 09 Oct 2026

Periprosthetic joint infection develops around an artificial joint implant and can be especially difficult to manage after knee replacement. More...

Treatment may require removal of the implant, prolonged infection control, and later reconstruction, while temporary joint support and local antibiotic delivery must be maintained in the interim. A newly cleared device is designed to address these needs by combining antibiotic delivery with load-bearing support.

Mass General Brigham (Boston, MA, USA) researchers have developed a temporary knee spacer that has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The device is intended for patients who develop infection around an artificial knee implant. After the infected implant is removed, the spacer maintains the joint space and provides structural support until a new artificial joint can be placed.

The spacer incorporates gentamicin into ultra-high-molecular-weight polyethylene, or UHMWPE. This medical-grade plastic is a durable, wear-resistant polymer that is commonly used in artificial joints. By embedding the antibiotic into UHMWPE, the device is designed to release gentamicin directly into the infected joint while preserving the mechanical strength needed to support the patient during treatment.

Infection occurs after approximately 2% of knee replacement surgeries. Standard treatment typically involves multiple operations and placement of a temporary spacer made from antibiotic-loaded bone cement. These cement spacers may provide limited support and may release antibiotics inconsistently, creating a need for more predictable structural and antimicrobial performance.

The technology grew out of research at the Harris Orthopaedics Laboratory. In a 2025 study published in The Journal of Bone & Joint Surgery, investigators reported that very small gentamicin particles produced higher and more sustained antibiotic release. The same approach preserved more than 90% of the polymer’s original mechanical strength.

Mass General Brigham Innovation helped advance the technology from laboratory research toward commercialization. The organization secured patent protection and worked with industry partners with product-development and market expertise. It is also in the process of licensing the intellectual property rights to a large implant manufacturer.

“Our goal was to create a spacer that can deliver antibiotics directly to the affected joint while remaining strong enough to support patients during treatment. This clearance is an important step toward making that technology available for patient care,” said Orhun K. Muratoglu, PhD, director of the Harris Orthopaedics Laboratory and vice chair of clinical innovation in the Department of Orthopedic Surgery at Mass General Brigham.

Related Links
Mass General Brigham


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Fluorescence image of water-acetone mixture condensation. (Photo courtesy of Jingcheng Ma/Interfacial Thermofluids Laboratory)

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more

Business

view channel
From left: Mr Ng Tian Chong, Chief Executive Officer, Singtel Singapore; Professor Yeoh Khay Guan, Chief Executive, NUHS; and Mr Daniel Ode, Head of Ericsson Singapore, Brunei and Philippines and Global Customer Unit Singtel, signed a Memorandum of Understanding to advance connected healthcare, 5G-Advanced and 6G technology, as well as connected intelligence. (Photo courtesy of National University Health System)

Healthcare Partnership Creates Testbed for Advanced Connectivity and AI Applications

Hospitals face growing care complexity, aging populations, and pressure to extend monitoring beyond traditional inpatient settings. Meeting these demands requires more responsive clinical workflows and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.